Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent

@inproceedings{Morales2008EvolutionOI,
  title={Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent},
  author={Alvaro Ru{\'i}z Morales},
  year={2008}
}
Background: The intra-cavitary administration of antineoplastic agents for the treatment of non-invasive bladder cancer has met with variable results. Mytomicin-C is effective in the prevention of tumor recurrence when administered in the immediate post-resection period, but also exhibits activity against papillary tumors. It lacks efficacy in carcinoma in-situ (CIS) of the bladder. Bacillus Calmette-Guerin (BCG) has been shown to be effective against papillary tumors, but particularly in the… CONTINUE READING

Topics from this paper.

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Emerging intravesical therapies for management of nonmuscle invasive bladder cancer

  • Open access journal of urology
  • 2010
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED